190 related articles for article (PubMed ID: 36811349)
1. Muramyl dipeptide alleviates estrogen deficiency-induced osteoporosis through canonical Wnt signaling.
Park OJ; Kwon Y; Kim J; Park C; Yun CH; Han SH
J Pathol; 2023 Jun; 260(2):137-147. PubMed ID: 36811349
[TBL] [Abstract][Full Text] [Related]
2. Muramyl dipeptide enhances osteoclast formation induced by lipopolysaccharide, IL-1 alpha, and TNF-alpha through nucleotide-binding oligomerization domain 2-mediated signaling in osteoblasts.
Yang S; Takahashi N; Yamashita T; Sato N; Takahashi M; Mogi M; Uematsu T; Kobayashi Y; Nakamichi Y; Takeda K; Akira S; Takada H; Udagawa N; Furusawa K
J Immunol; 2005 Aug; 175(3):1956-64. PubMed ID: 16034140
[TBL] [Abstract][Full Text] [Related]
3. Dimethyloxalylglycine prevents bone loss in ovariectomized C57BL/6J mice through enhanced angiogenesis and osteogenesis.
Peng J; Lai ZG; Fang ZL; Xing S; Hui K; Hao C; Jin Q; Qi Z; Shen WJ; Dong QN; Bing ZH; Fu DL
PLoS One; 2014; 9(11):e112744. PubMed ID: 25394221
[TBL] [Abstract][Full Text] [Related]
4. Rehmanniae Radix Preparata suppresses bone loss and increases bone strength through interfering with canonical Wnt/β-catenin signaling pathway in OVX rats.
Liu C; Wang L; Zhu R; Liu H; Ma R; Chen B; Li L; Guo Y; Jia Q; Shi S; Zhao D; Mo F; Zhao B; Niu J; Fu M; Orekhov AN; Brömme D; Gao S; Zhang D
Osteoporos Int; 2019 Feb; 30(2):491-505. PubMed ID: 30151623
[TBL] [Abstract][Full Text] [Related]
5. Roxadustat promotes osteoblast differentiation and prevents estrogen deficiency-induced bone loss by stabilizing HIF-1α and activating the Wnt/β-catenin signaling pathway.
Li L; Li A; Zhu L; Gan L; Zuo L
J Orthop Surg Res; 2022 May; 17(1):286. PubMed ID: 35597989
[TBL] [Abstract][Full Text] [Related]
6. Hydrolyzed egg yolk peptide prevented osteoporosis by regulating Wnt/β-catenin signaling pathway in ovariectomized rats.
Chen C; Huang L; Chen Y; Jin J; Xu Z; Liu F; Li K; Sun Y
Sci Rep; 2024 May; 14(1):10227. PubMed ID: 38702443
[TBL] [Abstract][Full Text] [Related]
7. Piezoelectric Microvibration Mitigates Estrogen Loss-Induced Osteoporosis and Promotes Piezo1, MicroRNA-29a, and Wnt3a Signaling in Osteoblasts.
Wu RW; Lian WS; Chen YS; Ko JY; Wang SY; Jahr H; Wang FS
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502380
[TBL] [Abstract][Full Text] [Related]
8. The effects of Liuwei Dihuang on canonical Wnt/β-catenin signaling pathway in osteoporosis.
Xia B; Xu B; Sun Y; Xiao L; Pan J; Jin H; Tong P
J Ethnopharmacol; 2014 Apr; 153(1):133-41. PubMed ID: 24530448
[TBL] [Abstract][Full Text] [Related]
9. Hydrogen gas protects against ovariectomy-induced osteoporosis by inhibiting NF-κB activation.
Wu G; Pan L; Sun J; Chen G; Wang S
Menopause; 2019 Jul; 26(7):785-792. PubMed ID: 31083022
[TBL] [Abstract][Full Text] [Related]
10. Foxf1 knockdown promotes BMSC osteogenesis in part by activating the Wnt/β-catenin signalling pathway and prevents ovariectomy-induced bone loss.
Shen G; Ren H; Shang Q; Zhao W; Zhang Z; Yu X; Tang K; Tang J; Yang Z; Liang D; Jiang X
EBioMedicine; 2020 Feb; 52():102626. PubMed ID: 31981979
[TBL] [Abstract][Full Text] [Related]
11. A Novel, Direct NO Donor Regulates Osteoblast and Osteoclast Functions and Increases Bone Mass in Ovariectomized Mice.
Kalyanaraman H; Ramdani G; Joshua J; Schall N; Boss GR; Cory E; Sah RL; Casteel DE; Pilz RB
J Bone Miner Res; 2017 Jan; 32(1):46-59. PubMed ID: 27391172
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-539 promotes osteoblast proliferation and differentiation and osteoclast apoptosis through the AXNA-dependent Wnt signaling pathway in osteoporotic rats.
Zhu XB; Lin WJ; Lv C; Wang L; Huang ZX; Yang SW; Chen X
J Cell Biochem; 2018 Nov; 119(10):8346-8358. PubMed ID: 29893431
[TBL] [Abstract][Full Text] [Related]
13. Muramyl Dipeptide, a Shared Structural Motif of Peptidoglycans, Is a Novel Inducer of Bone Formation through Induction of Runx2.
Park OJ; Kim J; Yang J; Yun CH; Han SH
J Bone Miner Res; 2017 Jul; 32(7):1455-1468. PubMed ID: 28337794
[TBL] [Abstract][Full Text] [Related]
14. Anti-Osteoporotic Activity of Harpagoside by Upregulation of the BMP2 and Wnt Signaling Pathways in Osteoblasts and Suppression of Differentiation in Osteoclasts.
Chung HJ; Kim WK; Oh J; Kim MR; Shin JS; Lee J; Ha IH; Lee SK
J Nat Prod; 2017 Feb; 80(2):434-442. PubMed ID: 28106392
[TBL] [Abstract][Full Text] [Related]
15. Muramyl dipeptide enhances lipopolysaccharide-induced osteoclast formation and bone resorption through increased RANKL expression in stromal cells.
Ishida M; Kitaura H; Kimura K; Sugisawa H; Aonuma T; Takada H; Takano-Yamamoto T
J Immunol Res; 2015; 2015():132765. PubMed ID: 26000311
[TBL] [Abstract][Full Text] [Related]
16. Melatonin Suppresses Estrogen Deficiency-Induced Osteoporosis and Promotes Osteoblastogenesis by Inactivating the NLRP3 Inflammasome.
Xu L; Zhang L; Wang Z; Li C; Li S; Li L; Fan Q; Zheng L
Calcif Tissue Int; 2018 Oct; 103(4):400-410. PubMed ID: 29804160
[TBL] [Abstract][Full Text] [Related]
17. Carfilzomib alleviated osteoporosis by targeting PSME1/2 to activate Wnt/β-catenin signaling.
Zhang F; Attarilar S; Xie K; Han C; Qingyang Liang ; Huang K; Lan C; Wang C; Yang C; Wang L; Mozafari M; Li K; Liu J; Tang Y
Mol Cell Endocrinol; 2022 Jan; 540():111520. PubMed ID: 34838695
[TBL] [Abstract][Full Text] [Related]
18. Pulsed electromagnetic fields (PEMF) attenuate changes in vertebral bone mass, architecture and strength in ovariectomized mice.
Lei T; Liang Z; Li F; Tang C; Xie K; Wang P; Dong X; Shan S; Jiang M; Xu Q; Luo E; Shen G
Bone; 2018 Mar; 108():10-19. PubMed ID: 29229438
[TBL] [Abstract][Full Text] [Related]
19. Amyloid β peptide promotes bone formation by regulating Wnt/β-catenin signaling and the OPG/RANKL/RANK system.
Yang B; Li S; Chen Z; Feng F; He L; Liu B; He T; Wang X; Chen R; Chen Z; Xie P; Rong L
FASEB J; 2020 Mar; 34(3):3583-3593. PubMed ID: 31944393
[TBL] [Abstract][Full Text] [Related]
20. Chrysosplenetin promotes osteoblastogenesis of bone marrow stromal cells via Wnt/β-catenin pathway and enhances osteogenesis in estrogen deficiency-induced bone loss.
Hong G; He X; Shen Y; Chen X; Yang F; Yang P; Pang F; Han X; He W; Wei Q
Stem Cell Res Ther; 2019 Aug; 10(1):277. PubMed ID: 31464653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
